US Preventive Services Task Force, Owens DK, Davidson KW, et2020
Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement
JAMA, 323(10), 970-975
查看原文 ↗Chou R, Dana T, Fu R, Zakher B, Wagner J, Ramirez S, Grusing2020
Screening for Hepatitis C Virus Infection in Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
JAMA
查看原文 ↗Carrat F, Fontaine H, Dorival C, et al2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
The Lancet, 393(10179), 1453-1464,32111-1)
查看原文 ↗Backus LI, Belperio PS, Shahoumian TA, Mole LA2019
Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease
Hepatology, 69(2), 487-497
查看原文 ↗Jakobsen JC, Nielsen EE, Feinberg J, et al2017
Direct-acting antivirals for chronic hepatitis C
Cochrane Database of Systematic Reviews, CD012143.pub3,(反方)
查看原文 ↗World Health Organization2026
Hepatitis C(事实清单,2026-07-28)
查看原文 ↗中华医学会肝病学分会, 中华医学会感染病学分会2022
丙型肝炎防治指南(2022 年版)
中华肝脏病杂志, 30(12), 1332-1348
查看原文 ↗国家卫生健康委办公厅等九部门2021
关于印发消除丙型肝炎公共卫生危害行动工作方案(2021-2030 年)的通知(国卫办疾控函〔2021〕492 号)
查看原文 ↗国家医疗保障局2019
《关于将 2019 年谈判药品纳入乙类范围的通知》政策解读
查看原文 ↗